Mentions of internet of things increased in the pharmaceutical industry in Q1 2023
Notably, internet of things was one of the most frequently referenced themes in Q1 2023, ranking highest in terms of mentions, ahead of governance and artificial intelligence, according to GlobalData.
Of the top leading companies in the pharmaceutical industry, Moderna had the greatest increase in references for internet of things in Q1 2023, compared with the previous quarter. GlobalData identified 1 internet of things-related sentences in the company’s filings – 3% of all sentences – and an increase of 100% in Q1 2023 compared with Q1 2022. Sarepta Therapeutics’s mentions of internet of things rose by 100% to 1.
GlobalData’s Company Filings Analytics also applies sentiment weight to reference sentences, based on whether the sentences are positive, negative, or neutral. Starting at 100 in 2020, an index over 100 is more positive. The overall index for internet of things in Q1 2023 was 77.
To further understand GlobalData’s analysis on Internet of Things market, buy the report here.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s Company Filings Analytics uses machine learning to uncover key insights and track sentiment across millions of regulatory filings and other corporate disclosures for thousands of companies across the world’s largest industries.
Source link
#Mentions #internet #increased #pharmaceutical #industry
